Seguir
Joan M Lakoski
Joan M Lakoski
Director of Investigator Development, WVCTSI
Dirección de correo verificada de hsc.wvu.edu
Título
Citado por
Citado por
Año
Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity
DW Gallager, JM Lakoski, SF Gonsalves, SL Rauch
Nature 308 (5954), 74-77, 1984
3521984
Hyperpolarization of serotonergic neurons by serotonin and LSD: studies in brain slices showing increased K+ conductance
GK Aghajanian, JM Lakoski
Brain research 305 (1), 181-185, 1984
2831984
Advancing institutional efforts to support research mentorship: A conceptual framework and self-assessment tool
DJ Keyser, JM Lakoski, S Lara-Cinisomo, DJ Schultz, VL Williams, ...
Academic Medicine 83 (3), 217-225, 2008
1742008
The interaction of cocaine with serotonin dorsal raphe neurons: Single-unit extracellular recording studies.
KA Cunningham, JM Lakoski
Neuropsychopharmacology, 1990
1591990
Effects of ketanserin on neuronal responses to serotonin in the prefrontal cortex, lateral geniculate and dorsal raphe nucleus
JM Lakoski, GK Aghajanian
Neuropharmacology 24 (4), 265-273, 1985
1351985
Restricted feeding with scheduled sucrose access results in an upregulation of the rat dopamine transporter
NT Bello, KL Sweigart, JM Lakoski, R Norgren, A Hajnal
American Journal of Physiology-Regulatory, Integrative and Comparative …, 2003
1342003
Electrophysiological effects of cocaine and procaine on dorsal raphe serotonin neurons
KA Cunningham, JM Lakoski
European journal of pharmacology 148 (3), 457-462, 1988
1311988
Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress
JE Cavanaugh, JD Jaumotte, JM Lakoski, MJ Zigmond
Journal of neuroscience research 84 (6), 1367-1375, 2006
1112006
Functional μ opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats
SR Chen, KL Sweigart, JM Lakoski, HL Pan
The Journal of the American Society of Anesthesiologists 97 (6), 1602-1608, 2002
902002
Duloxetine pharmacology: profile of a dual monoamine modulator
KD Karpa, JE Cavanaugh, JM Lakoski
CNS drug reviews 8 (4), 361-376, 2002
742002
Cocaine interaction withc entral monoaminergic systems: electrophysiological approaches
JM Lakoski, KA Cunningham
Trends in pharmacological sciences 9 (5), 177-180, 1988
721988
Spinal clonidine inhibits neural firing in locus coeruleus
J Marwaha, JH Kehne, RL Commissaris, J Lakoski, W Shaw, M Davis
Brain research 276 (2), 379-383, 1983
711983
Effect of muscimol on single unit activity of substantia nigra dopamine neurons
JR Walters, JM Lakoski
European journal of pharmacology 47 (4), 469-471, 1978
661978
The advantages and limitations of calmatives for use as a non-lethal technique
JM Lakoski, WB Murray, JM Kenny
totse. com, 2007
532007
Effects of histamine, H1-and H2-receptor antagonists on the activity of serotonergic neurons in the dorsal raphe nucleus.
JM Lakoski, GK Aghajanian
Journal of Pharmacology and Experimental Therapeutics 227 (2), 517-523, 1983
461983
Interaction of histamine H2-receptor antagonists with GABA and benzodiazepine binding sites in the CNS
JM Lakoski, GK Aghajanian, DW Gallager
European journal of pharmacology 88 (2-3), 241-245, 1983
451983
RDS-127 (2-di-n-propylamino-4, 7-dimethoxyindane): central effects of a new dopamine receptor agonist.
SP Arnerić, JP Long, M Williams, DB Goodale, J Mott, JM Lakoski, ...
Journal of Pharmacology and Experimental Therapeutics 224 (1), 161-170, 1983
441983
Central Serotonergic Neuronal Systems: Cellular Electrophysiologic Approaches
JM Lakoski, KA Cunningham
NIDA Research Monograph, 78, 1976
431976
Cellular electrophysiological approaches to the central regulation of female reproductive aging
JM Lakoski
Neurology and neurobiology 50, 209-220, 1989
401989
Effects of ergolines on dopaminergic and serotonergic single unit activity
JR Waiters, MD Baring, JM Lakoski
Dopaminergic ergot derivatives and motor function, 207-221, 1979
361979
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20